KDA|
|
IMAGE VIEW
Current issue Volume 47(6); November 2023
-
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, et al.
Diabetes Metab J. 2023;47(6):719-742.
ReviewSeptember 14, 2023
-
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh
Diabetes Metab J. 2023;47(6):743-756.
ReviewSeptember 6, 2023
-
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee Jung
Diabetes Metab J. 2023;47(6):757-766.
ReviewJuly 24, 2023
- Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association Youngmee Jee Diabetes Metab J. 2023;47(6):767-768. Special EditorialNovember 24, 2023
- Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin Sang Youl Rhee Diabetes Metab J. 2023;47(6):769-770. EditorialNovember 24, 2023
-
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice
Samaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, Seung Kyum Kim
Diabetes Metab J. 2023;47(6):771-783.
Original ArticleSeptember 8, 2023
-
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition
Ho Gyun Lee, Il Hyeon Jung, Byong Seo Park, Hye Rim Yang, Kwang Kon Kim, et al.
Diabetes Metab J. 2023;47(6):784-795.
Original ArticleAugust 23, 2023
-
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, et al.
Diabetes Metab J. 2023;47(6):796-807.
Original ArticleFebruary 9, 2023
-
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, et al.
Diabetes Metab J. 2023;47(6):808-817.
Original ArticleSeptember 26, 2023
- The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study Jun Sung Moon, Il Rae Park, Sang Soo Kim, Hye Soon Kim, Nam Hoon Kim, et al. Diabetes Metab J. 2023;47(6):818-825. Original ArticleNovember 24, 2023
-
ReviewSep 14, 2023
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, et al.
Diabetes Metab J. 2023;47(6):719-742.
-
ReviewSep 6, 2023
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh
Diabetes Metab J. 2023;47(6):743-756.
-
ReviewJul 24, 2023
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee Jung
Diabetes Metab J. 2023;47(6):757-766.
- Special EditorialNov 24, 2023 Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association Youngmee Jee Diabetes Metab J. 2023;47(6):767-768.
- EditorialNov 24, 2023 Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin Sang Youl Rhee Diabetes Metab J. 2023;47(6):769-770.
-
Original ArticleSep 8, 2023
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice
Samaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, et al.
Diabetes Metab J. 2023;47(6):771-783.
Special thematic issues
Best paper of the year
-
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus Eun Hee Kim, Hong-Kyu Kim, Min Jung Lee, et al.
-
Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial Jae Hyun Bae, Chang Ho Ahn, Ye Seul Yang, et al.
-
Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus Soyeon Kang, Yong-Moon Park, Dong Jin Kwon, et al.
-
Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study Zhi-Hui Zhang, Jiang-Feng Ke, Jun-Xi Lu, et al.
v.47(5) 9 2023
v.47(4) 7 2023
v.47(3) 5 2023
v.47(2) 3 2023
v.47(1) 1 2023
v.46(6) 11 2022
v.46(5) 9 2022
v.46(4) 7 2022
v.46(3) 5 2022
v.46(2) 3 2022
v.46(1) 1 2022
